It is tempting to speculate that the effect of mithramycin‐mediated displacement of SWI/SNF can be generalized to the 20% of all human cancer characterized by mutated or dysregulated SWI/SNF, though more research is needed to explore this hypothesis. Here, SMARCA1 is linked to cancer.